LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
-15.38%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$605M
AUM Growth
-$43.1M
(-6.6%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
10.61%
Top 10 Holdings %
Top 10 Hldgs %
48.94%
Holding
2,935
New
350
Increased
1,175
Reduced
756
Closed
208
Top Buys
| 1 |
Golub Capital BDC
GBDC
|
+$23.6M |
| 2 |
Oaktree Specialty Lending
OCSL
|
+$11.8M |
| 3 |
Microsoft
MSFT
|
+$3.22M |
| 4 |
Apple
AAPL
|
+$3.05M |
| 5 |
RPAR Risk Parity ETF
RPAR
|
+$1.9M |
Top Sells
| 1 |
Digital Turbine
APPS
|
+$2.38M |
| 2 |
Blackstone Mortgage Trust
BXMT
|
+$1.84M |
| 3 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.69M |
| 4 |
DBGI
Digital Brands Group, Inc. Common Stock
DBGI
|
+$1.37M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$1.06M |
Sector Composition
| 1 | Financials | 18.89% |
| 2 | Technology | 11.63% |
| 3 | Healthcare | 5.08% |
| 4 | Consumer Discretionary | 3.93% |
| 5 | Energy | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Kennedy-Wilson Holdings
KW
$1.24B
| $3K | ﹤0.01% |
144
+115
| +397% | +$2.4K |
|
|
LADR
1827
Ladder Capital
LADR
$1.48B
| $3K | ﹤0.01% |
238
-402
| -63% | -$5.07K |
|
1828
LendingClub
LC
$1.91B
| $3K | ﹤0.01% |
232
+198
| +582% | +$2.56K |
|
1829
Lineage Cell Therapeutics
LCTX
$306M
| $3K | ﹤0.01% |
1,754
| – | – |
|
1830
Lemonade
LMND
$3.88B
| $3K | ﹤0.01% |
144
| – | – |
|
1831
Lantheus
LNTH
$3.6B
| $3K | ﹤0.01% |
52
+9
| +21% | +$519 |
|
1832
Medifast
MED
$154M
| $3K | ﹤0.01% |
19
+4
| +27% | +$632 |
|
1833
MidCap Financial Investment
MFIC
$1.16B
| $3K | ﹤0.01% |
320
+49
| +18% | +$459 |
|
1834
MGE Energy Inc
MGEE
$3.08B
| $3K | ﹤0.01% |
36
-4
| -10% | -$333 |
|
1835
MKS Inc. Common Stock
MKSI
$7.73B
| $3K | ﹤0.01% |
29
-84
| -74% | -$8.69K |
|
1836
Modine Manufacturing
MOD
$7.86B
| $3K | ﹤0.01% |
245
+188
| +330% | +$2.3K |
|
1837
Morningstar
MORN
$10.8B
| $3K | ﹤0.01% |
12
-4
| -25% | -$1K |
|
|
MTLS
1838
Materialise
MTLS
$302M
| $3K | ﹤0.01% |
191
| – | – |
|
1839
Nektar Therapeutics
NKTR
$926M
| $3K | ﹤0.01% |
46
-47
| -51% | -$3.07K |
|
1840
Insight Enterprises
NSIT
$3.9B
| $3K | ﹤0.01% |
+30
| New | +$3K |
|
1841
Nutanix
NTNX
$21.2B
| $3K | ﹤0.01% |
171
-117
| -41% | -$2.05K |
|
1842
NovoCure
NVCR
$1.36B
| $3K | ﹤0.01% |
46
-5
| -10% | -$326 |
|
1843
O-I Glass
OI
$1.99B
| $3K | ﹤0.01% |
238
+164
| +222% | +$2.07K |
|
1844
Oceaneering
OII
$2.43B
| $3K | ﹤0.01% |
274
-188
| -41% | -$2.06K |
|
1845
Oil States International
OIS
$341M
| $3K | ﹤0.01% |
502
-80
| -14% | -$478 |
|
1846
Outset Medical
OM
$243M
| $3K | ﹤0.01% |
15
+4
| +36% | +$800 |
|
|
OPRA
1847
Opera Ltd
OPRA
$1.76B
| $3K | ﹤0.01% |
699
+329
| +89% | +$1.41K |
|
|
ORC
1848
Orchid Island Capital
ORC
$1.04B
| $3K | ﹤0.01% |
228
+169
| +286% | +$2.22K |
|
1849
Ormat Technologies
ORA
$5.53B
| $3K | ﹤0.01% |
36
+18
| +100% | +$1.5K |
|
1850
Old Republic International
ORI
$10B
| $3K | ﹤0.01% |
142
+36
| +34% | +$761 |
|